A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

Clinical Site, Sandy Springs

Clinical Site, Macon

Clinical Site, North Miami Beach

Clinical Site, Birmingham

Clinical Site, Murfreesboro

Clinical Site, Murray

Clinical Site, New Albany

Clinical Site, Columbus

Clinical Site, Canton

Clinical Site, Waterford

Clinical Site, Clarkston

Clinical Site, New Brighton

Clinical Site, Omaha

Clinical Site, Dallas

Clinical Site, San Antonio

Clinical Site, Northridge

Clinical Site, Fredericton

Clinical Site, Barrie

Clinical Site, Guelph

Clinical Site, Markham

Clinical Site, Peterborough

Clinical Site, Toronto

Clinical Site, Saskatoon